Inhibition of MEK/ERK upregulates GSH production and increases RANKL-induced osteoclast differentiation in RAW 264.7 cells

References

• Jimi E. The role of osteoclastic bone resorption on bone remodeling. Clin Calcium. 2017;27:1689–1695.
   PubMedGoogle Scholar
• Arias CF, Herrero MA, Echeverri LF, et al. Bone remodeling: a tissue-level process emerging from cell-level molecular algorithms. Plos One. 2018;13:e0204171.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhi X, Wang J, et al. RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation. Bone Res. 2018;6:34.
   PubMed Web of Science ®Google Scholar
• Pirapaharan DC, Olesen JB, Andersen TL, et al. Catabolic activity of osteoblast lineage cells contributes to osteoclastic bone resorption in vitro. J Cell Sci. 2019;132:jcs229351.
   PubMed Web of Science ®Google Scholar
• Chen X, Wang Z, Duan N, et al. Osteoblast-osteoclast interactions. Connect Tissue Res. 2018;59:99–107.
   PubMed Web of Science ®Google Scholar
• Cosman F. Long-term treatment strategies for postmenopausal osteoporosis. Curr Opin Rheumatol. 2018;30:420–426.
   PubMed Web of Science ®Google Scholar
• Zhou CH, Meng JH, Yang YT, et al. Cepharanthine prevents estrogen deficiency-induced bone loss by inhibiting bone resorption. Front Pharmacol. 2018;9:210.
   PubMed Web of Science ®Google Scholar
• Ihn HJ, Kim JA, Bae YC, et al. Afatinib ameliorates osteoclast differentiation and function through downregulation of RANK signaling pathways. BMB Rep. 2017;50:150–155.
   PubMed Web of Science ®Google Scholar
• Yao Z, Lei W, Duan R, et al. RANKL cytokine enhances TNF-induced osteoclastogenesis independently of TNF receptor associated factor (TRAF) 6 by degrading TRAF3 in osteoclast precursors. J Biol Chem. 2017;292:10169–10179.
   PubMed Web of Science ®Google Scholar
• Park JH, Lee NK, Lee SY. Current understanding of RANK signaling in osteoclast differentiation and maturation. Mol Cells. 2017;40:706–713.
   PubMed Web of Science ®Google Scholar
• Cong Q, Jia H, Li P, et al. p38α MAPK regulates proliferation and differentiation of osteoclast progenitors and bone remodeling in an aging-dependent manner. Sci Rep. 2017;7:45964.
   PubMed Web of Science ®Google Scholar
• Kim BH, Oh JH, Lee NK. The inactivation of ERK1/2, p38 and NF-κB is involved in the down-regulation of osteoclastogenesis and function by A2B adenosine receptor stimulation. Mol Cells. 2017;40:752–760.
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Kogawa M, Wada S, et al. Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1. J Biol Chem. 2004;279:45969–45979.
   PubMed Web of Science ®Google Scholar
• Li S, Yang B, Teguh D, et al. Amyloid β peptide enhances RANKL-induced osteoclast activation through NF-κB, ERK, and calcium oscillation signaling. Int J Mol Sci. 2016;17:1683.
   Web of Science ®Google Scholar
• Kang IS, Kim C. NADPH oxidase gp91phox contributes to RANKL-induced osteoclast differentiation by upregulating NFATc1. Sci Rep. 2016;6:38014.
   PubMed Web of Science ®Google Scholar
• Balkan W, Martinez AF, Fernandez I, et al. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand. Gene. 2009;446:90–98.
   PubMed Web of Science ®Google Scholar
• Oh JH, Lee JY, Park JH, et al. Obatoclax regulates the proliferation and fusion of osteoclast precursors through the inhibition of ERK activation by RANKL. Mol Cells. 2015;38:279–284.
   PubMed Web of Science ®Google Scholar
• Sompallae R, Stavropoulou V, Houde M, et al. The MAPK signaling cascade is a central hub in the regulation of cell cycle, apoptosis and cytoskeleton remodeling by tripeptidyl-peptidase II. Gene Regul Syst Bio. 2008;2:253–265.
   PubMedGoogle Scholar
• Hotokezaka H, Sakai E, Kanaoka K, et al. U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells. J Biol Chem. 2002;277:47366–47372.
   PubMed Web of Science ®Google Scholar
• Lee K, Seo I, Choi MH, et al. Roles of mitogen-activated protein kinases in osteoclast biology. Int J Mol Sci. 2018;19:3004.
   Web of Science ®Google Scholar
• Li M, Wang W, Geng L, et al. Inhibition of RANKL-induced osteoclastogenesis through the suppression of the ERK signaling pathway by astragaloside IV and attenuation of titanium-particle-induced osteolysis. Int J Mol Med. 2015;36:1335–1344.
   PubMed Web of Science ®Google Scholar
• Ihn HJ, Lee D, Lee T, et al. The 1,2,3-triazole derivative KP-A021 suppresses osteoclast differentiation and function by inhibiting RANKL-mediated MEK-ERK signaling pathway. Exp Biol Med (Maywood). 2015;240:1690–1697.
   PubMed Web of Science ®Google Scholar
• Lee SE, Woo KM, Kim SY, et al. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone. 2002;30:71–77.
   PubMed Web of Science ®Google Scholar
• Cao H, Zhu K, Qiu L, et al. Critical role of AKT protein in myeloma-induced osteoclast formation and osteolysis. J Biol Chem. 2013;288:30399–30410.
   PubMed Web of Science ®Google Scholar
• Liu Z, Ren Z, Zhang J, et al. Role of ROS and nutritional antioxidants in human diseases. Front Physiol. 2018;9:477.
   PubMed Web of Science ®Google Scholar
• Kemp M, Go YM, Jones DP. Nonequilibrium thermodynamics of thiol/disulfide redox systems: a perspective on redox systems biology. Free Radic Biol Med. 2008;44:921–937.
   PubMed Web of Science ®Google Scholar
• Cao JJ, Picklo MJ. N-acetylcysteine supplementation decreases osteoclast differentiation and increases bone mass in mice fed a high-fat diet. J Nutr. 2014;144:289–296.
   PubMed Web of Science ®Google Scholar
• Kim H, Kim IY, Lee SY, et al. Bimodal actions of reactive oxygen species in the differentiation and bone-resorbing functions of osteoclasts. FEBS Lett. 2006;580:5661–5665.
   PubMed Web of Science ®Google Scholar
• Hyeon S, Lee H, Yang Y, et al. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation. Free Radic Biol Med. 2013;65:789–799.
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhou X, Shi C, et al. α-lipoic acid protects against the oxidative stress and cytotoxicity induced by cadmium in HepG2 cells through regenerating glutathione regulated by glutamate-cysteine ligase. Toxicol Mech Methods. 2015;25:596–603.
   PubMed Web of Science ®Google Scholar
• Kim SK, Abdelmegeed MA, Novak RF. The mitogen-activated protein kinase kinase (MEK) inhibitor PD98059 elevates primary cultured rat hepatocyte glutathione levels independent of inhibiting MEK. Drug Metab Dispos. 2006;34:683–689.
   PubMed Web of Science ®Google Scholar
• Kim C, Dinauer MC. Rac2 is an essential regulator of neutrophil nicotinamide adenine dinucleotide phosphate oxidase activation in response to specific signaling pathways. J Immunol. 2001;166:1223–1232.
   PubMed Web of Science ®Google Scholar
• Srisook K, Cha YN. Biphasic induction of heme oxygenase-1 expression in macrophages stimulated with lipopolysaccharide. Biochem Pharmacol. 2004;68:1709–1720.
   PubMed Web of Science ®Google Scholar
• Tsubaki M, Komai M, Itoh T, et al. Nitrogen-containing bisphosphonates inhibit RANKL- and M-CSF-induced osteoclast formation through the inhibition of ERK1/2 and Akt activation. J Biomed Sci. 2014;21:10.
   PubMed Web of Science ®Google Scholar
• Boyce BF, Xing L, Yao Z, et al. Src inhibitors in metastatic bone disease. Clin Cancer Res. 2006;12:6291s–6295s.
   PubMed Web of Science ®Google Scholar
• Xing L, Venegas AM, Chen A, et al. Genetic evidence for a role for Src family kinases in TNF family receptor signaling and cell survival. Genes Dev. 2001;15:241–253.
   PubMed Web of Science ®Google Scholar
• Chen ZH, Saito Y, Yoshida Y, et al. Regulation of GCL activity and cellular glutathione through inhibition of ERK phosphorylation. BioFactors. 2008;33:1–11.
   PubMed Web of Science ®Google Scholar
• Fujita H, Ochi M, Ono M, et al. Glutathione accelerates osteoclast differentiation and inflammatory bone destruction. Free Radic Res. 2019;53:226–236.
   PubMed Web of Science ®Google Scholar
• Aoyama K, Nakaki T. Impaired glutathione synthesis in neurodegeneration. Int J Mol Sci. 2013;14:21021–21044.
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim N. Regulation of NFATc1 in osteoclast differentiation. J Bone Metab. 2014;21:233–241.
   PubMedGoogle Scholar
• Circu ML, Aw TY. Glutathione and modulation of cell apoptosis. Biochim Biophys Acta. 2012;1823:1767–1777.
   PubMed Web of Science ®Google Scholar
• Domazetovic V, Marcucci G, Iantomasi T, et al. Oxidative stress in bone remodeling: role of antioxidants. Clin Cases Miner Bone Metab. 2017;14:209–216.
   PubMedGoogle Scholar
• Ha H, Kwak HB, Lee SW, et al. Reactive oxygen species mediate RANK signaling in osteoclasts. Exp Cell Res. 2004;301:119–127.
   PubMed Web of Science ®Google Scholar
• Burdo J, Schubert D, Maher P. Glutathione production is regulated via distinct pathways in stressed and non-stressed cortical neurons. Brain Res. 2008;1189:12–22.
   PubMed Web of Science ®Google Scholar
• Levasseur R, Barrios R, Elefteriou F, et al. Reversible skeletal abnormalities in γ-glutamyl transpeptidase-deficient mice. Endocrinology. 2003;144:2761–2764.
   PubMed Web of Science ®Google Scholar
• Yamada K, Tsuji T, Kunieda T. Phenotypic characterization of Ggt1 (dwg/dwg) mice, a mouse model for hereditary γ-glutamyl transferase deficiency. Exp Anim. 2013;62:151–157.
   PubMed Web of Science ®Google Scholar
• Agidigbi TS, Kim C. Reactive oxygen species in osteoclast differentiation and possible pharmaceutical targets of ROS-mediated osteoclast diseases. Int J Mol Sci. 2019;20:3576.
   Web of Science ®Google Scholar
• Kanzaki H, Shinohara F, Kajiya M, et al. The Keap1/Nrf2 protein axis plays a role in osteoclast differentiation by regulating intracellular reactive oxygen species signaling. J Biol Chem. 2013;288:23009–23020.
   PubMed Web of Science ®Google Scholar